Treatment of cancer using GFR alpha-4 chimeric antigen receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11970525
APP PUB NO 20210079059A1
SERIAL NO

17078903

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions and methods for treating diseases, disorders or conditions associated with the expression of the Glycosyl-phosphatidylinositol (GPI)-linked GDNF family α-receptor 4 (GFRα4).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF FLORIDA BOARD OF TRUSTEES223 GRINTER HALL GAINESVILLE FL 32611

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhoj, Vijay Philadelphia, US 12 25
Milone, Michael C Cherry Hill, US 73 2761
Rader, Christoph Jupiter, US 41 836
Siegel, Donald L Lansdale, US 26 201

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 30, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 30, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 30, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00